Speaker illustration

Doctor Birgid Gonska

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)

Member of:

European Society of Cardiology

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Thumbnail

Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions

Thumbnail